Literature DB >> 10630501

Lack of effect of transdermal nicotine on 3 cases of primary sclerosing cholangitis.

G Jørgensen, H L Waldum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10630501     DOI： 10.1023/a:1026639106272

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  3 in total

1.  Primary sclerosing cholangitis is associated with nonsmoking: a case-control study.

Authors:  E V Loftus; W J Sandborn; W J Tremaine; D W Mahoney; A R Zinsmeister; K P Offord; L J Melton
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

2.  Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study.

Authors:  P Angulo; A E Bharucha; R A Jorgensen; C K DeSotel; W J Sandborn; N F Larusso; K D Lindor
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

3.  Risk of primary sclerosing cholangitis is associated with nonsmoking behavior.

Authors:  K J van Erpecum; S J Smits; P C van de Meeberg; F H Linn; F H Wolfhagen; G P vanBerge-Henegouwen; A Algra
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.